Patricia joined Brandon Capital in 2022.
Previously, Patricia worked as Corporate Development Manager at oNKo-innate, a discovery-stage biotechnology company dedicated to immune-oncology target identification and therapeutic development. Previous to this role, Patricia worked as project manager on the drug discovery collaboration between Monash institute of Pharmaceuticals Sciences (MIPS) and pharma company Servier, investigating novel modes of regulation of GPCRs in an effort to identify novel targets or approaches for drug discovery.
Through her professional career, Patricia has gained experience in translational project management, advancing projects for the development of diverse modalities targeting different therapeutic areas, and at different stages of the drug discovery process, from early target validation to late lead optimization phase. Additionally, she developed skills needed for commercial target/project analysis, critical to her current Analyst role as part of the CUREator team.
Patricia received her education and performed her graduate studies at the University of Jaen in Spain, continuing her training as a postdoc at the Parisian Institute Pasteur, gaining critical skills and experience that prepared her for her career in drug discovery and biomedical research and development.